Does MIGALASTAT Cause Product dose omission issue? 41 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Product dose omission issue have been filed in association with MIGALASTAT (Galafold). This represents 8.5% of all adverse event reports for MIGALASTAT.
41
Reports of Product dose omission issue with MIGALASTAT
8.5%
of all MIGALASTAT reports
0
Deaths
25
Hospitalizations
How Dangerous Is Product dose omission issue From MIGALASTAT?
Of the 41 reports, 25 (61.0%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIGALASTAT. However, 41 reports have been filed with the FAERS database.
What Other Side Effects Does MIGALASTAT Cause?
Renal impairment (34)
Off label use (29)
Death (26)
Fatigue (26)
Headache (25)
Cerebrovascular accident (23)
Nausea (20)
Drug ineffective (19)
Dyspnoea (19)
Pain (19)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which MIGALASTAT Alternatives Have Lower Product dose omission issue Risk?
MIGALASTAT vs MIGLITOL
MIGALASTAT vs MIGLUSTAT
MIGALASTAT vs MILNACIPRAN
MIGALASTAT vs MILRINONE
MIGALASTAT vs MILTEFOSINE